Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhuhai Livzon Diagnostics
Zhuhai, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Zhuhai Livzon Diagnostics holds leading market share in respiratory infections, infectious diseases, and drug concentration monitoring in China, with many products achieving 50-90% market share in their respective categories.[1]
- Therapeutic areas
- HematologyImmunologyOtherInfectious DiseasesOncology
- Modalities
- In-vitro diagnostic reagents
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Fujirebio (Japan)Siemens (Germany)MP Biomedicals (USA)
Beyond the preview
Go deeper on Zhuhai Livzon Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhuhai Livzon Diagnostics.